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GENERATION  OF  ANTIBODY  DIVERSITY  IN THE  IMMUNE 
RESPONSE  OF  BALB/c  MICE  TO  INFLUENZA  VIRUS 
HEMAGGLUTININ* 
I. Significant Variation  in Repertoire Expression between Individual Mice 
BY LOUIS  M.  STAUDT AND WALTER  GERHARD 
From the  Wistar Institute  of Anatomy  and Biology, Philadelphia,  Pennsylvania  19104 
Much has been learned about the diversity of antibody responses to haptens and 
carbohydrates  (1,  2),  yet  comparatively  little  is  known  about  the  generation  of 
antibody diversity in the response to protein antigens. In the present study, we have 
analyzed the diversity of the adult BALB/e antibody response to the hemagglutinin 
(HA) 1 of the influenza A/PR/8/34  (PRS)  virus using both paratypic and idiotypic 
analyses of anti-HA hybridoma antibodies. 
The  paratope  of an  anti-HA  antibody  can  be  defined  by  the  antibody's  fine 
specificity for a  panel of antigenically related influenza  A  viruses.  Previous studies 
have demonstrated  extensive  paratypic diversity in  the  BALB/c  anti-HA response 
using a panel of eight epidemic influenza A viruses in the fine specificity analysis (3- 
5).  More recently (6), we have refined the paratypic analysis by adding to the virus 
panel PR8 mutant viruses that possess single amino acid substitutions  in the HA. In 
the present study we have used a panel of 39 distinct PR8 mutant viruses along with 
12 epidemic influenza A  viruses to characterize the fine specificities of 125 BALB/c 
anti-HA hybridoma antibodies. In general, anti-HA antibodies can be classified into 
four broad specificity groups, i.e., groups of antibodies having related fine specificities. 
We have suggested that these four specificity groups correspond to four antigenic sites 
(designated sites Sa, Sb, Ca, and Cb) on the HA (6).  This is consistent with the four 
antigenic sites predicted  from the recently published  three-dimensional  structure of 
the HA (7,  8).  Thus,  the paratope of an anti-HA antibody can be characterized  in 
two related ways. First,  an anti-HA antibody can be characterized by its specificity 
for one of the four antigenic sites on the HA. Second, antibodies binding to a  given 
antigenic  site  can  be  further  distinguished  from  each  other  on  the  basis  of their 
patterns of reactivity with individual mutant viruses. 
By combining this  fine specificity analysis with  an idiotypic analysis of anti-HA 
antibodies,  we have addressed  three  questions:  (a)  what  is the size of the  anti-HA 
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repertoire of adult BALB/c mice? (b) Is the anti-HA repertoire equivalently expressed 
in each  individual BALB/c mouse?  (c)  What mechanisms are used to  generate the 
diversity  of  the  anti-HA repertoire  and  which  germ  line  variable  (V)  genes  are 
involved? 
Materials and Methods 
The Anti-HA Hybridoma Antibody Panel.  Hybridomas were generated by fusion of lymphocytes 
from the spleen and/or mediastinal lymph nodes of 14 adult (8- to 16-wk-old)  BALB/c mice 
after secondary or, in the case of mouse 35, primary immunization  with influenza A/PRS/8/34 
(PRS)  (H1N1).  The myelomas P3  ×  63Ag8  (9), P3  x  63Ag8-cl.653  (10) or Sp2/0Agl4 (11) 
were  used  in  these  fusions that  were  performed  as  previously described  (12). 125  of the 
hybridoma antibodies were shown to be reactive with the HA molecule of PR8 based on their 
reactivities with recombinant influenza viruses possessing known reassortments of genes of PR8 
and the distantly related influenza virus A/Hong Kong/68 (H3N2)  (13). Presently available 
evidence indicates further  that  these  hybridoma antibodies are  directed  against  antigenic 
determinants of the HA1 polypeptide (48,000 mol wt)  of the HA molecule. The hybridomas 
were grown in vitro in Dulbecco's modified Eagles  medium (DME) supplemented with 7.5% 
fetal calf serum and 7.5% agamma horse serum (both from Flow Laboratories, Rockville, MD), 
2 mM glutamine, and 50/~g/ml gentamycin (DME-S). In the designation for each hybridoma, 
the first  number after the  letter H  denotes the  individual BALB/c mouse from which the 
hybridoma was generated. 
Quantitation and Isotype Determination of Anti-HA  Hybridomas.  The concentration of anti-HA 
antibodies in culture fluids was determined in the viral radioimmunoassay (RIA)  (see below) 
by comparing the binding of hybridoma antibodies to  the binding of known quantities of 
affinity-purified BALB/c anti-PR8 antibody (14). Bound antibody was detected by means of 
radioiodinated rabbit anti-mouse-(Fab')2 antibodies. The same viral RIA was  also used  to 
determine the heavy (H) chain isotype of the anti-viral antibodies. In the latter assay, bound 
hybridoma antibody was detected by incubation  first with rabbit antisera specific for individual 
murine H chain isotypes and, second, with radioiodinated goat anti-rabbit antibodies (15). 
Viruses.  The PR8 mutant viruses were selected as described (16) by growing plaque-cloned 
parental virus PR8 [A/PR/8/34 (H 1N1)], originally obtained from Mt. Sinai Hospital, New 
York,  in the presence of individual anti-HA antibodies. Current evidence indicates that these 
viruses differ from the parental virus by single residue changes in the HA1 polypeptide (17). 
Each  of the  39  PRS-mutants used  in the  present analysis exhibits an antigenically unique 
modification. In addition, 12 standard epidemic virus strains of the H 1N1 subtype were used. 
The HA molecules of the latter virus strains differ from the HA molecule of PR8 by many 
residue changes yet the HA molecules remain serologically  related. The presently used abbre- 
viations and full designations of these viruses are: SW: A/Swine/31 (H1N1); WSN: A/WSN/ 
33  (H1N1);  MEL: A/Melbourne/35 (H1N1);  BH: A/BH/35  (H1N1);  HIC: A/Hickcox/40 
(H 1N 1  ); BEL: A/Bellamy/42 (H 1N 1  ); WEI: A/Weiss/43 (H 1N 1); CAM: A/Cam/46 (H 1N 1); 
FMI:  A/Fort  Monmouth/I/47 (H1N1);  FW:  A/Fort  Wyoming/I/50 (H1N1);  MAL:  A/ 
Malaya/302/54 (H1N1); DEN: A/Denver/57 (H1N1). 
All viruses were grown in embryonated hen's eggs, purified by banding in a sucrose gradient 
and quantitated by HA titration using chicken erythrocytes as previously described (14). The 
purified viruses  were  stored  at  4°C  in phosphate-buffered saline (PBS)  pH  7.2, containing 
0.08% sodium azide (HAS). 
Viral RIA.  Viral immunoadsorbents  were prepared in two ways. In the case of PR8 mutant 
viruses,  immunoadsorbent stock  solutions were prepared by incubating 2 x  105 hemaggluti- 
nating units (HAU) of purified virus per ml HAS with 1% Nonidet P-40 for 30 rain at 37°C. 
The virus solution was then diluted 10-fold with HAS and stored as a stock solution at 4°C. 
Immunoadsorbents  were prepared by incubating 25/~1 of a 1  : 100 dilution in HAS of the above 
stock solutions in individual  wells of polyvinyl  microtiter plates (Cooke Engineering,  Alexandria, 
VA) overnight at room temperature. In the case of the epidemic virus strains, immunoadsorbents 
were prepared as described (12) by drying 25/~1 of virus in HAS (corresponding to 20 HAU) LOUIS M.  STAUDT AND WALTER  GERHARD  689 
into wells of polyvinyl mictotiter plates. Before use in the RIA, the plates were incubated for at 
least 1 h with HAS containing 1% bovine serum albumin. 
The RIA was performed by incubating 25 #1 of a  dilution of hybridoma culture fluid (in 
HAS containing 10% agamma horse serum) for 90 min with the solid-phase viral immunoad- 
sorbents. The wells were then washed, incubated for 90 rain with 25 pl of radioiodinated rabbit 
anti-mouse-F(ab')z antibodies, washed, and the amount of radioactivity bound to individual 
wells determined in a  gamma counter. Each culture fluid was first  assayed to determine the 
concentration of antibody binding to the parental virus (PR8)  immunoadsorbent. The fine 
specificity  of each  antibody was  then  determined as  follows.  A  dilution of culture  fluid 
containing  0.5-1 ng antibody/25/.tl (referred  to as the standard dilution) was tested for binding 
to the various viral immunoadsorbents. In parallel, serial 2  -0.5 dilutions  of the standard dilution 
were assayed on the parental virus to generate a standard binding  curve for each antibody. The 
cpm observed in the interaction of the antibody with each heterologous virus was then related 
to the antibody's  standard curve and was expressed,  on a log 2 basis, as percent binding  relative 
to the parental virus. The resulting reactivity pattern  (RP)  of each antibody represents the 
average of at least  three independently performed assays.  The final binding values have an 
average standard deviation of 0.37  (6). 
Antibody Purification.  All hybridoma antibodies were purified from serum-free hybridoma 
culture fluid (18). Hybridomas were first  grown in DME-S. The ceils were spun out of the 
medium (8 rain, 300 g) when they had reached a density of ~ 10  e cells/ml and were transferred 
to DME containing  insulin (Sigma Chemical Co., St. Louis, Mo.) (5 #g/ml), transferrin (Sigma 
Chemical Co.),  (5 #g/ml), glutamine (2 raM), and gentamyein (50 #g/ml). The euhure fluid 
was collected every 24 h for 3 d by spinning  the cells out of the medium and transferring them 
to fresh serum-free DME. The cell density was kept at 1.5-2 ×  106 eeils/ml. 
Antibodies ofy2a, y2b, and -),3 isotypes were purified by passing 500 ml of serum-free culture 
fluid  (adjusted  to  pH  8)  over  a  7-ml  Sepharose  4B-protein  A  column  (Pharmacia  Fine 
Chemicals, Piscataway, N  J). The antibody was eluted in a linear pH gradient (pH 7 to pH 3) 
using the 0.2 M Britton-Robinson  buffer (BRB) consisting of 0.029 N citric acid monohydride, 
0.058 N potassium phosphate monobasic, 0.029 N barbital, and 0.087 N boric acid. Hybridoma 
antibodies  of  yl  isotype  were  concentrated  from  500  ml  of serum-free  culture  fluid  by 
ultrafiltration using an immersible-CX ultrafilter (Millipore Corp.,  Bedford, MA), dialyzed 
against 0.2 M  BRB pH 8 and then applied to the protein A column, which was equilibrated 
with 0.2  M  BRB,  pH  8.  After washing the column with  15  ml of 0.2  M  BRB,  pH  8,  the 
antibody was eluted using the same pH gradient as described above. Myeloma proteins were 
purified by standard methods  from  ascites.  All purified antibodies were  concentrated and 
dialyzed against PBS by uhrafiltration. Protein concentration  was determined using the Biorad 
protein assay (Bio-Rad Laboratories, Richmond, CA). 
Antiidiotypic Antisera.  New Zealand white rabbits were injected subcutaneously in multiple 
sites  with  300 pg of purified hybridoma antibody emulsified in complete adjuvant H37Ra 
(Difco  Laboratories, Detroit, MI). The rabbits were boosted intramuscularly with  100 #g of 
purified  hybridoma antibody in  PBS,  and  sera  were  collected  10  d  later.  The  antiserum 
prepared against H37-68  (yl, x)  was  absorbed with the myeloma protein MOPC-21  (yl, x) 
coupled to Sepharose 4B. The antiserum raised against H36-5 (y3, to) was absorbed with normal 
BALB/c immunoglobulin  coupled to Sepharose 4B for use in the H36-5 idiotype (Id) assay to 
remove  V,21  light  (L)  chain-specific antibodies contained in  this  serum.  The  anti-H36-5 
antiserum used in the V,21C cross-reactive  Id (IdX) assay was only absorbed with the myeloma 
protein J606 (y3, x). The rabbit antisera to K chains from MOPC-70E (V~21A) and ABPC 22 
(V,2 I B), raised as previously described (19-21), were kindly provided by M. Weigert and M. 
Julius (Institute for Cancer Research, Fox Chase, Philadelphia, PA), D. McKean (Department 
of Immunology, Mayo Medical School,  Rochester, MN), and M. Potter (Laboratory of Cell 
Biology, National Cancer Institute). 
Id  Competition RIA.  Absorbed  anti-Id antisera  were  diluted  (depending on  antiserum, 
1  : 10,000 to 1:25,000) in PBS, and 50 #l was added to wells of polyvinyl microtiter plates (Cooke 
Engineering, Alexandria, VA). The antibodies were allowed to adsorb to the wells by overnight 
incubation  at room temperature. The plates were then incubated for at least 1 h with 1% bovine 
serum  albumin in  HAS  before  being used  in  the  following competition assay:  25  #l  of 690  DIVERSITY OF BALB/c ANTIBODIES TO INFLUENZA VIRUS 
radioiodinated antibody (0.5-2 ng, corresponding to 10,000-20,000  cpm) and 25/A of dilutions 
of unlabeled antibody test  samples were  added  to  each  well.  The diluent for  labeled and 
unlabeled antibodies was HAS containing 10% agamma horse serum. The plates were then 
incubated for  3 h  at room temperature, washed four times, and the radioactivity bound to 
individual wells was determined in a gamma counter, Each assay was standardized by using 
known quantities of unlabeled homologous antibody as  competitor.  In general,  1-4  ng of 
homologous antibody gave 50% inhibition of binding of the labeled antibody probe. Heterol- 
ogous  hybridoma culture fluids were screened at a  1:5 dilution. At this dilution, all culture 
fluids contained at least 5 ng (in general, >20 ng) of antibody per 25 gl. The purified hybridoma 
antibodies were radiolabeled with carrier-free Na 12sI (Amersham Corp, Arlington Heights, IL) 
using the chloramine-T method (22). 
Production of Secondary BALB/c Anti-PR8 Sera.  Adult BALB/e mice were  immunized with 
1,000 HAU of PR8 virus intraperitoneally.  The mice were boosted 4 wk later with 1,000 HAU 
of PR8 intraperitonealty, and serum was collected individually  after 10 d. 
Results 
The  Size  of the  BALB/c  Anti-HA  Paratypic  Repertoire.  A  total  of  125  anti-HA 
hybridoma  antibodies,  generated  from  14  individual BALB/c  mice  mostly  after 
secondary immunization with PR8, were tested in the viral RIA for their binding to 
39 PR8 mutant viruses and 12 standard epidemic virus strains of the H1N1 subtype. 
Table  I  shows  that  the  antibodies  exhibit  104  distinct  reactivity  patterns  (RP). 
Consequently, the present panel of 125  anti-HA hybridoma antibodies contains at 
least  104 distinct clonotypes. Several small groups of antibodies exhibited identical 
RP. With three exceptions, the groups of antibodies having indistinguishable  RP were 
derived from the same individual mouse. The antibodies within each of these groups 
may, but do not necessarily have to, possess identical combining sites. Based on the 
data  in Table I,  the  most  likely size of the  adult BALB/c  anti-HA repertoire was 
estimated to be 1,500 using the statistical methods of Wybrow and Berryman (23). 
To  investigate  the  generation  of  this  large  repertoire,  we  chose  the  following 
TABLE  I 
Extent of Paratypic Diversity Among Anti-HA Hybridomas 
Number of anti-HA  Fusion number  Number of distinct RP  hybridomas isolated 
1  1  l 
2  8  8 
3  2  2 
8  7  7 
9  4  4 
16  2  1 
17  5  4 
18  11  8 
20  1  1 
28  5  5 
33  3  3 
35  9  9 
36  13  11 
37  54  43 
Reactivity patterns repeated in two fusions  -3 
Total  125  104 LOUIS  M.  STAUDT  AND  WALTER  GERHARD  691 
approaches.  First,  given the apparent absence of a  predominant  anti-HA clonotype 
expressed  at  high  frequency  in  each  individual  BALB/c  mouse,  we  wanted  to 
investigate further the relationships existing among anti-HA antibodies derived from 
the same individual  mouse. For this reason, we saved all hybridomas obtained from 
the individual mice 36 and 37. Second, we screened the anti-HA hybridoma panel for 
the presence of Id that  are markers for variable (V)  region sequences derived from 
related germ line V  genes. Given the previous demonstration that L chains belonging 
to the V~21 group can be used in the anti-HA response of BALB/c mice (24,  25), we 
decided to concentrate on this group of germ line genes. 
The Idiotypy and Fine Specificities of Antibodies  Obtained from Individual Mice 
THE  ANTI-HA  HYBRIDOMA  PANEL  FROM  MOUSE  36.  13  anti-HA  hybridomas  were 
obtained  from  mouse  36  after  secondary  immunization  with  PR8,  and  the  fine 
specificities  of the  hybridoma  antibodies  are  shown  schematically  in  Fig.  1.  It  is 
evident that this "individual" antibody panel is rather restricted in specificity in that 
it contains predominantly (10 out of 13)  antibodies that bind to site Sb on the HA 
(i.e., nonreactivity with mutant viruses of the EV and/or BV mutant  virus groups). 
In particular, many antibodies exhibit decreased binding to the mutant viruses BV1, 
BV12,  and/or  BV13.  This RP has not been seen among 39 other antibodies  of Sb 
specificity that were derived from other individual BALB/c mice. 
A  rabbit  antiserum  was raised  against  antibody H36-5.  This  antibody has been 
serologically shown  to contain  a  L  chain  of the V~21C  subgroup  (see below).  The 
antiserum was therefore absorbed with  normal  BALB/c serum  immunoglobulin  to 
remove anti-V,21C antibodies as well as anti-constant region antibodies. All 125 anti- 
HA hybridoma culture fluids were then tested for their capacity to inhibit the binding 
of radioiodinated  H36-5  to  this  anti-Id  antiserum.  Only  three  culture  fluids  gave 
significant inhibition in this assay (>20%) and all three were from hybridomas (H36- 
5, H36-7, and H36-17) derived from individual mouse 36.  When purified hybridoma 
antibodies from mouse 36 were assayed (Fig. 2), H36-15 also produced a  significant 
inhibition of 30% when used at a  concentration of 4.1  #g/25 #1. On the other hand, 
antibodies H36-1, H36-4, and H36-18 showed no inhibition even at high  (4.1  #g/25 
#l)  concentration.  This is particularly striking since H36-1  and H36-18 are indistin- 
guishable in RP from the Id  + antibodies H36-5 and H36-15, respectively. 
When  this  same  anti-Id  serum  was  used  with  radiolabeled  H36-17  in  an  Id 
competition  RIA  (Fig.  3),  H36-5,  H36-7,  and  H36-17  all  gave  100%  inhibition. 
Similarly, when radiolabeled H36-7 was used, all three antibodies gave 100% inhibi- 
tion  (data not shown). This implies that these three antibodies share some idiotypic 
determinants  (i.e.,  the H36-5 Id). In these assays, H36-15 showed greater inhibition, 
but  still  only at  high  antibody concentrations.  Thus,  H36-15  must  have  idiotypic 
determinants that are weakly cross-reactive with some or all of the H36-5 Id deter- 
minants. On the basis of their shared idiotypic determinants and similar RP, H36-5, 
H36-7,  H36-17,  and  H36-15 will be considered  members of the H36-5  Id antibody 
family. Secondary anti-PR8 antisera from 75 individual BALB/c mice, containing on 
average -200/~g/ml of anti-HA antibody, were screened for the presence of the H36- 
5 Id using this assay. No antiserum gave >30% inhibition at a  1:20 dilution. Therefore, 
the concentration  of H36-5 Id within these antisera must be <0.4/~g/ml.  Thus, the H
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F~c.  2.  Id competition RIA using rabbit anti-H36-5 with ~aSI-labeled H36-5. The percent binding 
(average  of triplicate samples)  of the iodinated antibody was determined according to:  [(cpm  in 
presence  of competitor) -  BKG/(cpm in absence  of competitor) -  BKG] ×  100. The background 
(BKG) is the cpm in the absence of rabbit anti-H36°5. 
FIG.  3. 
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Id competition RIA using rabbit anti-I-I36-5 with l~5I-labeled H36-17.  See legend to Fig. 
H36-5 Id is a  rare anti-HA  Id that is nevertheless expressed on 31% of the hybridoma 
antibodies isolated from mouse 36. 
ThE ANTI-HA I"IYBRIDOMA  PANEL FROM MOUSE 37.  A  panel of 54 anti-HA hybridomas 
was isolated from the individual adult  BALB/c  mouse 37. The antibodies  from these 
hybridomas  were  found  to  have  43  distinct  RP  when  tested  on  the  panel  of PR8 
mutant  viruses  (Fig. 4)  and on the  12 epidemic influenza A  viruses (data not shown). 694 
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F]o. 4.  RP analysis of anti-HA antibodies obtained ~om individual BALB/e mouse 37 on PR8 
mutant viruses. See le~nd to Fig. 1. See text ~r details of the Id analysis. The H37-45 Id will be 
described in a separate publication (manuscript in preparation). 
Two  of these  RP  have  also  been  observed  among antibodies isolated  ~om  other 
individual BALB/c, but the m~ority of the RP are unique to mouse 37. Furthermore, 
the  fine specificity analysis revealed large  ~milies of paratypically similar but not 
identical antibodies.  For  example,  many antibodies showed  decreased  binding to 
BV1,  BV2,  BV6,  BV12,  and  BV13  with  and without  decreased  binding to  other 
mutant viruses. Similarly, a number of antibodies showed decreased binding to BV 13 
and/or TV3. Thus, there are clear paratypic similarities among the antibodies ~om 
mouse  37,  suggesting that  groups  of these  antibodies have  structurally related  V 
domains. 
To  ~rther  define the  structural relationships between these  antibodies, a  rabbit 
antiserum  was  raised  against  hybridoma  antibody  H37-68.  This  antiserum  was 
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absorbed with appropriate myeloma proteins to remove anti-constant region specific- 
ities  and  was  then  used  to  set  up  an  Id  competition  RIA  with  H37-68  as  the 
radiolabeled probe. This assay was fully inhibitable by purified PC6308, a  myeloma 
protein containing a V~21D L chain. Furthermore, when culture fluids from the  125 
anti-HA hybridomas were screened in this assay, the  10 culture fluids that gave full 
inhibition were the same ones that fully inhibited the V,21ADEF assay (see below). 
Therefore, this assay most likely detected V~21 L chain Id determinants. 
To circumvent this problem, the rabbit that had been immunized twice with H37- 
68  was  boosted  with  H37-24,  a  V~21ADEF  IdX-  antibody  (see  Fig.  4)  that  is 
paratypically similar  but  not  identical  to  H37-68.  After absorption with  myeloma 
proteins to remove anti-constant region specificities, this antiserum was used to set up 
an Id competition RIA using radiolabeled H37-24. This assay, termed the H37-68 Id 
assay, was not inhibited by the V~21D myeloma protein PC6308. When the anti-HA 
hybridoma culture  fluids  were  assayed  for  the  H37-68  Id,  28  culture  fluids  gave 
between 50 and  100% inhibition, while the remaining 97 culture fluids gave between 
0 and 30% inhibition.  27 of the H37-68 Id  + antibodies were derived from mouse 37 
and  thus  represent  50%  of all  anti-HA  hybridoma  antibodies  isolated  from  that 
mouse. One H37-68 Id  + antibody was isolated from mouse 18. Therefore, only 1.4% 
of the hybridoma antibodies  isolated  from  13  BALB/c mice  other than  mouse 37 
were positive for the H37-68 Id. 
When  purified  hybridoma antibodies  were  used  as  inhibitors  in  the  H37-68  Id 
assay,  it  became  clear  that  the  H37-68  Id  is  heterogeneous  (Fig.  5).  Four  of the 
purified antibodies tested had identical inhibition curves and gave full inhibition, but 
three  antibodies  only gave 60-70%  inhibition  at  high  antibody concentration.  Al- 
though these results demonstrate the heterogeneity of the H37-68 Id, it is clear that 
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there must be extensive sharing of idiotypes among the H37-68 Id  + antibodies, since 
they all gave >50% inhibition in the H37-68 Id assay. 
The  RP of the  27  H37-68  Id  + antibodies  from  mouse  37  (Fig.  4)  illustrate  two 
important points. As noted above, a  large group of paratypically related antibodies, 
characterized by reduced binding to BV1, BV2, BV6, BV12, and BV13, was isolated 
from mouse 37. These antibodies, with the exception of H37-87 and H37-543, were 
all H37-68 Id  +, which strengthens the possibility that these antibodies have structur- 
ally related V  domains. On the other hand, there is considerable paratypic diversity 
among these H37-68 Id  + antibodies,  in that the antibodies exhibited  18 distinct RP 
in the fine specificity analysis.  Furthermore,  four of these antibodies  (H37-59, H37- 
69, H37-104, and H37-91) appear to be paratypically quite dissimilar from the rest of 
the H37-68 Id  + antibodies. In summary, the H37-68 Id defines a family of antibodies 
that  (a)  is disproportionately represented among the antibodies isolated from mouse 
37,  (b)  displays idiotypic microheterogeneity, and  (c)  consists of both paratypically 
similar and dissimilar antibodies. 
Anti-HA Antibodies Bearing V~21 Group-related L  Chain Id.  To identify germ line V 
genes that are used to generate the diverse anti-HA repertoire, we made use of Id that 
are  found on ~  chain  variable  (V~) sequences  belonging to  the  same V~  group.  V 
groups consist of V  sequences that are highly homologous within the first  framework 
region (2). Within each V group, subgroups are defined by a linked series of subgroup 
specific residues that are scattered throughout the V  region in both framework and 
complementary determining regions. In the best-studied V~ group, V~21, six subgroups 
(A-F)  have been  defined  (19,  20).  Members of a  V~21 subgroup are thought to be 
derived from a single germ line V gene with or without somatic mutation (19, 20, 26). 
Thus,  idiotypic determinants  formed by subgroup-specific residues  should  be  ideal 
markers for a  given germ line V  gene (19-21). 
Three different competition RIA for V~21 subgroups were set up to screen the anti- 
HA hybridoma panel for the presence of these L chains. The assay shown in Fig. 6 a 
was most sensitive for V,21C, but also detected V~21D,  though to a  lesser  extent.  A 
second assay (Fig.  6 b)  detected predominantly V~21B,  but V~21C also gave partial 
inhibition.  The  third  assay  (Fig.  6C)  used  an  antiserum  that  was  characterized 
previously (21) as reacting most strongly with the V~21A, V,21D, V,21 E, and V~21F 
subgroups and partially with the V~21C  and V~21B subgroups. 
The  anti-HA hybridoma culture  fluids  were  tested  for inhibition  in  these  three 
assays  at  dilutions  containing between  10  and  100  ng of antibody.  A  hybridoma 
culture fluid was scored as V~21C IdX  + if it gave >80% inhibition in the V~21C assay 
and <50%  inhibition  in  the V~21B  and V~21ADEF assays. Analogous criteria were 
used to score hybridoma culture fluids as either V,21B IdX  + or V~21ADEF IdX  +. Of 
the  125 anti-HA hybridoma antibodies tested,  16 were positive for V,21C IdX,  1 for 
V~21B IdX, and  10 for V~21ADEF IdX. Thus,  22% of the anti-HA hybridomas use 
V~21 L chains. The V,21 IdX  + antibodies were isolated from seven individual BALB/ 
c  mice. 
The RP of the V~21 IdX  + hybridoma antibodies in the PR8 mutant virus analysis 
are  shown  in  Fig.  7.  23  of the  27  antibodies  bind  to  epitopes  in  or  near  the  Sb 
antigenic site since they have low reactivity with viruses in the Sb mutant group (i.e., 
EV  and  BV  mutants).  Of these  23  antibodies,  the  V,21C  IdX  + and  V~21B  IdX  + 
antibodies are clearly specific for site Sb. On the other hand, most of the V~21ADEF LOUIS  M.  STAUDT AND  WALTER  GERHARD  697 
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IdX  + antibodies also have decreased binding to some viruses in the Sa mutant group, 
suggesting that  these antibodies  bind  near the junction  of sites  Sa and  Sb.  Of the 
remaining  four  V,21  IdX  +  antibodies,  two  are  directed  against  site  Cb  and  two 
against  site  Ca.  Thus,  the  V,21  IdX  +  antibodies  bind  predominantly,  but  not 
exclusively, to site Sb on the HA. 
Discussion 
The present analysis of 125  anti-HA hybridoma antibodies  provides unequivocal 
evidence of the large diversity of the adult BALB/c anti-HA antibody response• Thus, 
on  the  basis of the reactivity of these antibodies  with  51  antigenically related  HA 
molecules, we could differentiate  104 paratypically unique antibodies.  Paratypically 
indistinguishable  antibodies  obtained  from  different  donor  mice were  observed  in 
only three instances. Based on this repeat frequency, the most likely size of the adult 
BALB/c  anti-HA  paratypic  repertoire  is  1,500,  as  calculated  by  the  method  of 
Wybrow and Berryman (23).  This estimate exceeds several-fold a previous estimate of 
the  paratypic  repertoire  size  based  on  a  similar  analysis  of monoclonal  anti-HA 
antibodies produced in the splenic fragment culture system (3-5). The latter studies 
were  performed,  however,  with  a  considerably  smaller  panel  of cross-reative  HA 
antigens and, as a consequence, failed to dissect two major specificity groups (i.e.,  Sa 
and  Sb)  of the BALB/c anti-HA repertoire into their individual  paratypic compo- 
nents.  It is very likely that the present estimate is still less than the actual size of the 
anti-HA repertoire  of adult  BALB/c  mice.  First,  the  inability  to  differentiate  two 
antibodies from each other by the present mutant virus analysis does not prove their 
paratypic identity. Second, one of the assumptions made in calculating the repertoire H
Y
B
R
I
D
O
M
A
 
H
3
6
-
1
7
 
H
3
6
-
7
 
H
5
6
-
5
 
H
3
6
-
 
I
 
H
 
3
6
 
-
 
1
5
 
H
3
6
-
1
8
 
H
3
7
-
6
3
 
H
3
7
-
3
8
 
H
3
7
-
B
5
 
H
3
7
-
7
7
 
H
3
7
-
B
7
 
H
2
8
-
0
1
~
 
H
2
8
-
E
2
3
 
H
2
-
6
C
4
 
H
3
5
-
C
9
 
H
3
5
-
C
7
 
H
3
7
-
2
3
 
H
3
7
-
5
4
3
 
H
3
7
-
6
B
 
H
3
7
-
7
0
 
H
3
7
-
5
4
5
 
H
3
7
-
7
9
 
H
3
7
-
6
5
 
H
3
7
-
5
2
 
H
3
7
-
9
4
 
H
8
-
2
D
I
 
H
3
-
4
C
5
 
H
 
C
H
A
I
N
 
I
S
O
T
Y
P
E
 
(
g
G
3
 
I
g
G
3
 
I
g
G
3
 
I
g
G
I
 
I
g
G
2
o
 
I
c
J
G
2
O
 
I
g
G
2
Q
 
I
g
G
2
o
 
I
g
G
2
a
 
I
g
G
~
'
a
 
I
g
G
I
 
I
g
G
2
a
 
I
c
/
G
2
o
 
I
g
M
 
i
g
G
2
a
 
l
g
G
2
a
 
I
g
G
2
a
 
l
g
G
2
o
 
I
g
G
 
I
g
G
 
I
g
G
 
I
g
G
 
I
g
G
 
)
g
G
 
I
g
G
 
I
g
G
3
 
I
g
G
l
 
V
K
2
1
 
S
U
B
G
R
O
U
P
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
B
 
A
D
E
F
 
A
D
E
F
 
A
D
E
F
 
A
D
E
F
 
A
D
E
F
 
A
O
E
F
 
A
D
E
F
 
A
D
E
F
 
A
D
E
F
 
A
D
E
F
 
P
R
B
-
M
U
T
A
N
T
 
V
I
R
U
S
E
S
 
S
o
 
S
b
 
C
o
 
C
b
 
P
'
 
C
v
 
K
V
 
P
V
 
"
 
E
V
 
B
V
 
"
 
T
V
 
Z
V
 
N
V
 
D
V
 
S
V
 
"
 
R
V
 
L
V
 
A
V
'
 
8
 
I
 
2
 
5
 
6
 
2
 
4
 
i
 
3
 
9
 
1
2
 
2
C
)
'
2
 
6
 
8
 
I
 
2
 
6
 
I
I
 
1
2
 
t
3
"
1
 
2
 
3
 
4
"
~
2
 
3
 
7
 
4
 
5
"
'
5
 
3
 
I
 
3
 
7
 
I
 
4
 
7
 
I
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
~
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
u
m
u
~
 
u
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
~
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
 
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
•
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
•
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
 
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
~
 
m
m
~
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
•
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
~
m
~
~
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
•
 
m
n
m
m
m
m
m
m
m
m
m
m
~
m
~
m
 
m
m
m
m
m
m
~
m
~
m
m
m
m
m
m
 
•
 
m
n
m
m
m
m
~
m
~
m
m
m
m
m
m
 
•
 
m
m
m
m
m
m
m
 
m
~
m
m
m
m
m
 
•
 
m
m
m
m
m
m
~
 
•
 
m
m
m
m
m
 
•
 
m
m
m
m
m
 
m
 
m
m
 
m
m
m
 
•
 
m
~
m
 
•
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
m
 
m
m
 
~
m
 
m
m
~
 
~
 
~
 
m
m
~
m
m
m
m
m
m
n
m
m
m
~
m
~
 
m
m
m
m
m
m
m
m
m
m
m
m
m
~
m
m
m
m
m
m
~
 
~
m
m
~
 
m
m
~
m
m
m
m
m
m
m
m
 
m
m
m
m
m
m
m
m
m
m
m
m
m
~
m
m
m
m
m
m
m
~
 
~
m
m
m
m
m
m
~
m
m
m
m
m
m
m
 
F
I
C
.
 
7
.
 
R
P
 
a
n
a
l
y
s
i
s
 
o
f
V
,
2
l
 
I
d
 
+
 
a
n
t
i
b
o
d
i
e
s
 
o
n
 
P
R
8
 
m
u
t
a
n
t
 
v
i
r
u
s
e
s
.
 
S
e
e
 
l
e
~
n
d
 
t
o
 
F
i
g
.
 
1
.
 
<
 
,
H
 
0
 
>
 
0
 
0
 
Z
 
b
l
 
>
 
<
 LOUIS M.  STAUDT AND WALTER GERHARD  699 
size is that each clonotype has an equal chance of selection in each individual mouse. 
However, the analysis of anti-HA antibodies  from individual  BALB/c mice in  the 
present  report  suggests  that  certain  Id  can  be present  at  a  high  frequency among 
antibodies from one individual yet be missing entirely among antibodies isolated from 
another individual. Finally, it should also be noted that the present estimate measures 
only that part of anti-HA sequence diversity which affects the paratypic properties of 
an antibody, and thus probably represents only a  fraction of the total BALB/c anti- 
HA diversity. 
Despite the extensive diversity of the anti-HA repertoire, there are families of anti- 
HA antibodies  that  have structurally  related  V  regions.  Thus,  the VK21 idiotypic 
analysis  defined  a  family of 27  anti-HA antibodies  derived  from seven  individual 
BALB/c mice that bear L chains belonging to the V,21 group. This family constitutes 
22%  of our anti-HA hybridoma panel.  Previous studies  have shown  that  ~8.6%  of 
normal BALB/c to-bearing serum immunoglobulin is V~21  IdX  + (21). Assuming that 
our anti-HA hybridoma panel is a fair cross-section of the BALB/c anti-HA repertoire, 
these  findings  suggest  that  the  V,21  group  is  used  preferentially  in  the  anti-HA 
response. In other words, out of an estimated 300 germline V, genes (19,  20,  27-29) 
only 6-8 related VK genes coding for the V,21  group (19,  20, 26)  are used to generate 
more than one-fifth of the anti-HA repertoire. 
Additional  families  of  idiotypically  related  anti-HA  antibodies  were  observed 
among antibodies isolated from the same individual  BALB/c mouse. Among the  13 
anti-HA antibodies  isolated  from mouse 36,  4  shared  the H36-5  Id, which  was not 
detected  among  112  anti-HA antibodies  derived  from  13 other individual  BALB/c 
mice or in secondary anti-PR8 antisera from 75 individual BALB/c mice. The RP of 
these four H36-5 Id  + antibodies on the panel of PR8 mutant viruses are quite similar 
to each other but clearly different from the RP of the anti-HA antibodies that were 
not  derived  from  mouse  36.  Why  was  the  H36-5  Id  only  found  among anti-HA 
antibodies  from one  individual  mouse? We suggest  that  the  H36-5  Id  +  antibodies 
were generated  by a  process of somatic diversification that  took place in  mouse 36 
and  is statistically unlikely to occur in exactly the same fasion  in  other individual 
BALB/c mice. We further suggest  that  the B  cells producing H36-5 Id  ÷ antibodies 
descended  from a  common precursor cell  in  mouse 36 and  that  the  paratypic and 
idiotypic diversity among these antibodies is due to somatic mutation (Fig. 8). 
To verify that  the H36-5  Id family descended  from a  common precursor cell  by 
somatic mutation, it must first be shown that the members of the H36-5 Id family are 
using somatic V  genes that are generated from the same germ line H  chain variable 
(Vn) and L chain variable (VL) genes. The V~21 idiotypic analysis demonstrated that 
all  members of the  H36-5  Id  family use V~21C  L  chains  and  thus  probably have 
somatically generated V, genes derived from the same germ line V, gene (19, 20, 26). 
Interestingly, antibodies H36-1 and H36-18, which lack the H36-5 Id, also use V,21C 
L  chains  and are paratypically quite  similar to the H36-5  Id family. This suggests 
that  the latter two antibodies  are also clonally related  to the  H36-5  Id family but 
have lost  the  H36-5  Id  in  the  course  of somatic  diversification.  This  possibility is 
supported by a DNA restriction enzyme analysis of the V,21G IdX  + hybridomas from 
mouse 36,  which  indicated  that  these hybridomas all have productively rearranged 
the same VI~ and VL genes (R. Luedtke and M. Weigert, manuscript in preparation). 
Additional  evidence for the common clonal origin of the V,21C  IdX  + cells from 700  DIVERSITY OF  BALB/c  ANTIBODIES TO  INFLUENZA VIRUS 
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Fro.  8.  Somatic diversification may generate differences in anti-HA repertoire between individual 
BALB/c mice. This schematic is based on the family of VK21C IdX  + antibodies isolated from mouse 
36 (see text for details). The model proposes that from a given precursor B cell with rearranged VH 
and VL germ line genes in individual A, a  clonotype could he somatically generated that has an 
individual  Id  (IdI-A:H36-5) that is a  marker for the particular process of somatic diversification 
that took place in that individual mouse. The paratope (P) of this clonotype is specit]c for site Sb on 
the HA and has fine specificity  1 [HA(Sb)-I]. Further somatic diversification can vary the IdI and 
the P independently, Starting with the same precursor B cell, individual B is unlikely to somatically 
generate a clonotype with the same IdI as was generated in individual A. 
mouse  36  comes  from  sequence  studies  of the  somatically  generated  V  domains. 
Amino terminal VH sequences from this family belong to the VH4 group and are very 
similar to the translated  protein sequence of gene V11,  one of the TEPC15-related 
germline VH genes recently sequenced by Crews et al. (30)  (R. Luedtke, D. McKean 
and M.  Weigert,  manuscript  in preparation).  Furthermore, the amino terminal VL 
sequences of these antibodies are, as predicted, closely related to the V~21C germline 
sequence (19).  (D. McKean, R. Luedtke, and M. Weigert, manuscript in preparation). 
However, each L  chain  differs by several amino acids  from the germline sequence. 
Notably, a number of these substitutions are shared by three to five of the antibodies 
within this family. These findings strongly support the notion that at least subsets of 
this  family were  derived  from  a  common  progenitor  B  cell  possessing  particular 
somatic mutations  that  were  conserved  in  its  progeny.  Each  antibody  within  this 
family is  a  distinct  clonotype,  as judged  by the  idiotypic  and  paratypic  analyses. 
Therefore, if all the V~21C  IdX  + cells from mouse 36 did,  in  fact, have a  common 
clonal origin, then the somatic mutational  process was apparently quite  active and 
may  reflect  the  action  of a  specialized  hypermutational  mechanism  such  as  that 
postulated by Kim et al. (31). 
The  H37-68  Id,  like  the  H36-5  Id,  defined  a  family  of  antibodies  that  was 
predominantly expressed in a  single individual  mouse. However, a  major difference 
between H37-68 Id family and the H36-5 Id family is that the H37-68 Id  + antibodies 
appear to have L  chains of at least three different V~ subgroups based on the V~21 
IdX assays (see  Fig.  4). These assays detected  2  H37-68 Id  + antibodies that have L 
chains of the V~21C subgroup, 7 antibodies that have L chains of the V~21A, D, E, or 
F  subgroups,  and  18  antibodies  whose  L  chains  are serologically unrelated  to  any 
known  V~21  L  chain  subgroup.  Since  the  serological  assays used  here  are  able  to 
detect  L  chains  of all known V~21  subgroups,  and since each V~ subgroup  is most LOUIS M.  STAUDT AND WALTER GERHARD  701 
likely derived from a separate germ line gene (19, 20, 26), one would have to conclude 
that the H37-68 Id  ÷ antibodies possess L chains derived from at least three different 
germ line V~ genes. Consequently, these data seem to imply that the H37-68 Id family 
did not  descend  from a  common precursor cell  (containing  both productively rear- 
ranged Via and VL genes) as hypothesized for the H36-5 Id family (above). However, 
if the V~21 idiotypic determinants were altered in the course of somatic diversification, 
either by somatic mutation, somatic recombination between related V  genes (28, 32), 
or gene conversion (33), then the H37-68 Id family could have had a common clonal 
origin.  Alternatively, the  H37-68  Id family could  have descended  from a  common 
pre-B  cell  with  a  productively  rearranged  VH  gene  (34,  35)  which  subsequently 
rearranged various VL genes. Ultimately, structural analysis of the V  domains within 
the H37-68 Id family should elucidate the clonal history of this family. 
Both  the  H36-5  Id  and  the  H37-68  Id,  although  rarely  expressed  within  the 
BALB/c strain as a  whole, were found on large and diverse families of hybridomas 
isolated from single individual mice. Recently, other investigators (36)  demonstrated 
that  three anti-HA (PR8)  hybridoma antibodies had distinct  paratypes and yet all 
shared an Id. Interestingly, these hybridomas constituted  all of the anti-HA  (PR8) 
hybridomas obtained  from one  individual  BALB/c  mouse  (J.  Schulman,  personal 
communication). Although  anti-HA (PR8)  hybridomas from other individuals were 
not assayed for this Id, these findings are consistent with the present observation of 
idiotypic sharing  by diverse anti-HA antibodies  isolated  from the  same individual 
mouse. 
What  factors could  account  for the  dominance  of rare Id  within  the  expressed 
repertoires of individual  mice? First, suppose that the B cells bearing such a  rare Id 
have  a  polyclonal  origin  within  an  individual  mouse.  In  this  case,  the  regulatory 
mechanisms  leading  to  the  dominance  of  these  clonotypes  must  be  directly  or 
indirectly  related  to  the  Id.  For example,  idiotypic  network  interactions  (37)  may 
differ  among  individuals  leading  to  the  expansion  of  rare,  idiotypically  related 
clonotypes within a  given individual mouse. Also, individual differences in antigenic 
history might  exist  such  that  a  particular  individual  may have been  exposed  to  a 
unique set of environmental antigens that primed B cells cross-reacting with the HA. 
These clonotypes might possess a common Id and could, upon subsequent experimen- 
tal immunization with the HA, dominate the individual's anti-HA response.  Alter- 
natively, suppose that the B cells bearing a rare Id within an individual mouse are all 
derived from a  single precursor B cell by somatic mutation, as discussed above. The 
progeny of a single precursor B cell might well share a rare Id and thus the regulatory 
mechanisms mentioned above may, but do not necessarily have to contribute to the 
expansion of these clonotypes within an individual.  Conceivably, the somatic muta- 
tional process within the clonal progeny of a  precursor B cell might be coupled with 
differentiation of these B  cells into rapidly proliferating cells that  could eventually 
dominate an individuals's anti-HA repertoire. 
Summary 
The  paratypic  and  idiotypic  diversity of the  BALB/c  antibody  response  to  the 
hemagglutinin (HA) of the influenza A/PR/8/34 virus (PR8) was investigated using 
a  panel of 125  anti-HA hybridoma antibodies derived from  14 BALB/c mice. The 
paratypic diversity, as assessed by a fine specificity analysis using 51 related influenza 702  DIVERSITY  OF BALB/c ANTIBODIES  TO INFLUENZA VIRUS 
viruses,  was  extensive:  104  distinct  paratopes  were  observed.  In  three  instances, 
antibodies with indistinguishable paratopes were isolated from two individual mice. 
A minimum estimate of the size of the adult BALB/c anti-HA paratypic repertoire, 
calculated from these data, is  1,500. 
The  generation  of this  diverse  repertoire  was  studied  by screening  the  anti-HA 
hybridoma panel for the presence of idiotypes (Id) that are markers for variable (V) 
region  sequences  derived  from  related  germ  line  V  genes.  Three  cross-reactive Id 
(IdX)  that  are  markers  for  the  V~21C,  V~21B,  and  V~21A,  D,  E,  or  F  L  chain 
subgroups were found, respectively on  16,  1, and  10 anti-HA hybridoma antibodies 
derived  from  seven  individual  BALB/c  mice.  Thus,  the  V~21 IdX  +  hybridomas 
constitute 22% of the anti-HA hybridoma panel.  The V~21 IdX are also present  on 
8.6% of K-bearing immunoglobulin in normal BALB/c serum. This suggests that the 
V~21 group is used preferentially in the BALB/c anti-HA immune response. 
The generation of the anti-HA repertoire was further studied using large panels of 
anti-HA hybridomas derived from two individual adult BALB/c mice. Anti-idiotypic 
antisera were raised in rabbits against individual hybridomas from each mouse. One 
anti-Id serum defined a family of four idiotypically and paratypically related, but not 
identical,  antibodies  from  mouse  36,  which  represented  31%  of  the  hybridoma 
antibodies isolated from this mouse. None of the  112 anti-HA hybridoma antibodies 
derived from 13 other individual mice showed idiotypic cross-reactivity. Furthermore, 
this Id could not be detected in anti-PR8 antisera from 75 individual BALB/c mice. 
Another anti-Id serum  defined a  family of 27 idiotypically related  antibodies  from 
mouse  37,  which  represented  50%  of the  hybridoma antibodies  isolated  from  this 
mouse. Only 1 of the 71 hybridoma antibodies isolated from 13 other individuals was 
idiotypically cross-reactive. 
These results demonstrate that individual adult BALB/c mice express paratypically 
and  idiotypically distinct  antibody repertoires  to  the  HA of influenza  virus  PR8. 
Based  on these observations, we suggest that  somatic mutation  plays an  important 
role in the generation of the adult anti-HA repertoire. Mechanisms that could account 
for differences in repertoire expression among individual mice are discussed. 
The excellent  technical  assistance of Alex Taylor, Dale  McCreedy,  and  Maureen  Carey is 
gratefully acknowledged. 
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